Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana Bosch

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2018
The Strategy of PIKing a Target: What Is AKTually Most Effective?Carlotta Costa, Ana Bosch
Cancer Treatment Reviews|December 20, 2011
Molecular biology in breast cancer: intrinsic subtypes and signaling pathwaysPilar Eroles, Ana Bosch, J Alejandro Pérez-Fidalgo, et al.
Oncotarget|July 27, 2016
High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancerSiker Kimbung, Barbara Lettiero, Maria Feldt, et al.
Cancer Treatment Reviews|January 12, 2010
Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of researchAna Bosch, Pilar Eroles, Rosa Zaragoza, et al.
Scientific Reports|March 21, 2024
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancerChristopher Godina, Mattias Belting, Johan Vallon-Christersson, et al.
Breast Cancer Research and Treatment|April 5, 2023
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancerChristopher Godina, Helga Tryggvadottir, Ana Bosch, et al.
Molecular & Cellular Oncology|June 17, 2016
Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatmentPau Castel, Eneda Toska, Zachary S Zumsteg, et al.
Breast Cancer Research : BCR|October 11, 2023
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithmsGudbjörg Sigurjonsdottir, Tommaso De Marchi, Anna Ehinger, et al.
Plos One|July 3, 2024
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcomeChristopher Godina, Somayeh Khazaei, Mattias Belting, et al.
The Biochemical Journal|March 30, 2010
Nitric oxide triggers mammary gland involution after weaning: remodelling is delayed but not impaired in mice lacking inducible nitric oxide synthaseRosa Zaragozá, Ana Bosch, Concha García, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2018
The Strategy of PIKing a Target: What Is AKTually Most Effective?Carlotta Costa, Ana Bosch
Cancer Treatment Reviews|December 20, 2011
Molecular biology in breast cancer: intrinsic subtypes and signaling pathwaysPilar Eroles, Ana Bosch, J Alejandro Pérez-Fidalgo, et al.
Oncotarget|July 27, 2016
High expression of cholesterol biosynthesis genes is associated with resistance to statin treatment and inferior survival in breast cancerSiker Kimbung, Barbara Lettiero, Maria Feldt, et al.
Cancer Treatment Reviews|January 12, 2010
Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of researchAna Bosch, Pilar Eroles, Rosa Zaragoza, et al.
Scientific Reports|March 21, 2024
Caveolin-1 gene expression provides additional prognostic information combined with PAM50 risk of recurrence (ROR) score in breast cancerChristopher Godina, Mattias Belting, Johan Vallon-Christersson, et al.
Breast Cancer Research and Treatment|April 5, 2023
Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancerChristopher Godina, Helga Tryggvadottir, Ana Bosch, et al.
Molecular & Cellular Oncology|June 17, 2016
Rationale-based therapeutic combinations with PI3K inhibitors in cancer treatmentPau Castel, Eneda Toska, Zachary S Zumsteg, et al.
Breast Cancer Research : BCR|October 11, 2023
Comparison of SP142 and 22C3 PD-L1 assays in a population-based cohort of triple-negative breast cancer patients in the context of their clinically established scoring algorithmsGudbjörg Sigurjonsdottir, Tommaso De Marchi, Anna Ehinger, et al.
Plos One|July 3, 2024
High Caveolin-1 mRNA expression in triple-negative breast cancer is associated with an aggressive tumor microenvironment, chemoresistance, and poor clinical outcomeChristopher Godina, Somayeh Khazaei, Mattias Belting, et al.
The Biochemical Journal|March 30, 2010
Nitric oxide triggers mammary gland involution after weaning: remodelling is delayed but not impaired in mice lacking inducible nitric oxide synthaseRosa Zaragozá, Ana Bosch, Concha García, et al.
Pageof 5